Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jun
4
2019
OIG Issues Alert to Warn of ‘Free’ Genetic Testing Scams Seeking to Steal Information Robinson & Cole LLP
Sep
3
2019
Spurred by Opioid Crisis, Government Proposes Additional Changes to Substance Use Disorder Confidentiality Regulations to Facilitate Provision of Coordinated Care Robinson & Cole LLP
Mar
25
2020
Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure Robinson & Cole LLP
Mar
26
2020
Massachusetts Issues COVID-19 Orders and Related Guidance for Pharmacies and Pharmacy Professionals Robinson & Cole LLP
Sep
1
2021
Considerations for Employers Thinking about COVID-19 Vaccine Mandates Robinson & Cole LLP
Sep
30
2021
Biometric Information Privacy Programs Robinson & Cole LLP
Apr
4
2019
Medical Marijuana Delivery App Agrees to Settle TCPA Case for $1.75M Robinson & Cole LLP
Sep
13
2022
A COVID-19 Laboratory Testing Conviction under EKRA Robinson & Cole LLP
Oct
31
2019
Legal Pot = Manufacturing Storm Clouds (the Refrain) Robinson & Cole LLP
Nov
5
2020
ShopRite Settles with NJ AG for Data Breach Robinson & Cole LLP
Jul
27
2021
Connecticut Legislature Passes Act to Help Address the Opioid Epidemic Robinson & Cole LLP
Jan
31
2019
OIG Advisory Opinion No. 19-02 Allows Pharmaceutical Manufacturer to Temporarily Loan Smartphones to Financially Needy Patients to Receive Data from a Digestible Medication Sensor Robinson & Cole LLP
Jun
4
2023
Unanimous Supreme Court Endorses Subjective Belief Standard for False Claims Liability Robinson & Cole LLP
Jan
28
2020
DOJ Reaches Settlement with Patient Assistance Foundation Resolving Allegations of FCA Violations Robinson & Cole LLP
Oct
24
2023
DEA Further Extends COVID-19 Telemedicine Prescribing Flexibilities through December 31, 2024 Robinson & Cole LLP
May
8
2020
Connecticut Governor Ned Lamont Issues Executive Order Allowing Pharmacists to Order COVID-19 Tests Robinson & Cole LLP
Feb
3
2022
COVID-19 Vaccine Update – February 2022 Robinson & Cole LLP
Sep
27
2022
DOJ Announces $900 Million Settlement Tied to Speaker Bureau Payments to Physicians Robinson & Cole LLP
Jun
15
2022
Supreme Court Decides in Favor of 340B Hospitals Regarding Medicare Reimbursement Methodology Robinson & Cole LLP
Jul
12
2019
Connecticut Legislature Modifies Statutes Relevant to Preventing and Treating Opioid Use Disorder Robinson & Cole LLP
Sep
24
2019
DOJ Reaches $21.36 Million Agreement with Compounding Pharmacy, Two of its Executives, and Managing Private Equity Firm to Resolve FCA Allegations Robinson & Cole LLP
Feb
15
2022
The Joint Commission Announces COVID-19 Vaccine Surveys Have Begun Robinson & Cole LLP
Jun
9
2023
Connecticut Governor’s Health Care Bill Makes Important Changes to the Certificate of Need Process Robinson & Cole LLP
Mar
18
2020
DEA Allows Providers to Prescribe Controlled Substances Without an In-Person Medical Examination During COVID-19 Public Health Emergency Robinson & Cole LLP
Jan
14
2021
Privacy Tip #267 – Fertility Tracking App Settles with FTC Robinson & Cole LLP
Jan
3
2019
Data Privacy and Security in the Cannabis Industry Robinson & Cole LLP
May
15
2019
CMS Final Rule on Drug Pricing Transparency in Consumer Television Ads Robinson & Cole LLP
Jul
3
2019
Privacy Tip #197 — Medtronic 508 (MiniMed) Insulin Pumps Recalled Robinson & Cole LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins